Literature DB >> 23888361

Treg cells in rheumatoid arthritis: an update.

Faye A H Cooles1, John D Isaacs, Amy E Anderson.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease arising from a breakdown in immunological self-tolerance, which leads to aberrant immune responses to autoantigens. Regulatory CD4(+) T-cells (Tregs) underpin one of the key mechanisms of self-tolerance and are a major focus of study in RA and other autoimmune diseases. In order to design new and improved therapies to reinstate self-tolerance, and perhaps cure disease, we need to understand the complex mechanism of action of Tregs. This review addresses recent findings in the field of Tregs in RA, with particular focus on identification of potential defects in Treg-mediated self-tolerance mechanisms present in RA patients, as well as how Tregs interact with other cells in the inflamed joints. As antigen-specific Tregs are a potential route for the reinstatement of immune tolerance, we also discuss new strategies currently being investigated which expand or induce de novo generation of Tregs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23888361     DOI: 10.1007/s11926-013-0352-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  85 in total

1.  Protein kinase C-theta mediates negative feedback on regulatory T cell function.

Authors:  Alexandra Zanin-Zhorov; Yi Ding; Sudha Kumari; Mukundan Attur; Keli L Hippen; Maryanne Brown; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells.

Authors:  Angela M Thornton; Patricia E Korty; Dat Q Tran; Elizabeth A Wohlfert; Patrick E Murray; Yasmine Belkaid; Ethan M Shevach
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

3.  Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.

Authors:  Louise A Swainson; Jeff E Mold; Urmila D Bajpai; Joseph M McCune
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

4.  CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.

Authors:  Fabian Flores-Borja; Anneleen Bosma; Dorothy Ng; Venkat Reddy; Michael R Ehrenstein; David A Isenberg; Claudia Mauri
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

5.  The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells.

Authors:  G Chen; J Hao; Y Xi; W Wang; Z Wang; N Li; W Li
Journal:  Scand J Immunol       Date:  2008-12       Impact factor: 3.487

6.  Modulation of IL-17 and Foxp3 expression in the prevention of autoimmune arthritis in mice.

Authors:  Joana Duarte; Ana Agua-Doce; Vanessa G Oliveira; João Eurico Fonseca; Luis Graca
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

7.  Treg cells suppress osteoclast formation: a new link between the immune system and bone.

Authors:  Mario M Zaiss; Roland Axmann; Jochen Zwerina; Karin Polzer; Eva Gückel; Alla Skapenko; Hendrik Schulze-Koops; Nikki Horwood; Andrew Cope; Georg Schett
Journal:  Arthritis Rheum       Date:  2007-12

8.  Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.

Authors:  Jenny L McGovern; Dao X Nguyen; Clare A Notley; Claudia Mauri; David A Isenberg; Michael R Ehrenstein
Journal:  Arthritis Rheum       Date:  2012-10

9.  Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis.

Authors:  Mattias N D Svensson; Sofia E M Andersson; Malin C Erlandsson; Ing-Marie Jonsson; Anna-Karin H Ekwall; Karin M E Andersson; Anders Nilsson; Li Bian; Mikael Brisslert; Maria I Bokarewa
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

10.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

View more
  36 in total

Review 1.  Molecular insights into phytochemicals exhibiting anti-arthritic activity: systematic review : John Di Battista.

Authors:  P Sivasakthi; E Sanmuga Priya; P Senthamil Selvan
Journal:  Inflamm Res       Date:  2021-05-24       Impact factor: 4.575

Review 2.  Immune cell profiling to guide therapeutic decisions in rheumatic diseases.

Authors:  Joerg Ermann; Deepak A Rao; Nikola C Teslovich; Michael B Brenner; Soumya Raychaudhuri
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

3.  Dysregulated ICOS+ proinflammatory and suppressive regulatory T cells in patients with rheumatoid arthritis.

Authors:  Hong-Xia Wang; Xia Kang; Shuai Chu; Haixia Li; Xin Li; Xiaofeng Yin; Yu-Rong Qiu; Weinan Lai
Journal:  Exp Ther Med       Date:  2018-08-24       Impact factor: 2.447

Review 4.  Vitamin D in rheumatoid arthritis-towards clinical application.

Authors:  Louisa E Jeffery; Karim Raza; Martin Hewison
Journal:  Nat Rev Rheumatol       Date:  2015-10-13       Impact factor: 20.543

5.  Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.

Authors:  A Ferreiro-Iglesias; A Montes; E Perez-Pampin; J D Cañete; E Raya; C Magro-Checa; Y Vasilopoulos; T Sarafidou; R Caliz; M A Ferrer; B Joven; P Carreira; A Balsa; D Pascual-Salcedo; F J Blanco; M J Moreno-Ramos; A Fernández-Nebro; M C Ordóñez; J J Alegre-Sancho; J Narváez; F Navarro-Sarabia; V Moreira; L Valor; R García-Portales; A Marquez; J Martin; J J Gómez-Reino; A Gonzalez
Journal:  Pharmacogenomics J       Date:  2015-04-21       Impact factor: 3.550

Review 6.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

Review 7.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 8.  Synovial cellular and molecular markers in rheumatoid arthritis.

Authors:  M Asif Amin; David A Fox; Jeffrey H Ruth
Journal:  Semin Immunopathol       Date:  2017-05-11       Impact factor: 9.623

9.  Vasoactive intestinal peptide is required in the maintenance of immune regulatory competency of immune regulatory monocytes.

Authors:  L Guan; D Yu; G-H Wu; H-J Ning; S-D He; S-S Li; T-Y Hu; G Yang; Z-Q Liu; H-Q Yu; X-Z Sun; Z-G Liu; P-C Yang
Journal:  Clin Exp Immunol       Date:  2019-01-30       Impact factor: 4.330

Review 10.  Extracorporeal photopheresis as a therapy for autoimmune diseases.

Authors:  Zoya Kuzmina; David Stroncek; Steven Z Pavletic
Journal:  J Clin Apher       Date:  2014-12-26       Impact factor: 2.821

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.